Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Poland / NCT06719752
Enrolling by invitation Not applicable

Assessing the Acute Effects of Diagonal Mobilization

NCT06719752 · tracked via the Priya Life Science Poland tracker
Sponsor
Medical University of Gdansk
Phase
Not applicable
Started
2025-02-25
Last updated
2025-02-25

Condition(s) studied

Aged 14 to 16Play Football Regularly

Investigational drug(s) / intervention(s)

Placebo

Placebo: Placebo intervention; the therapy will mimic exceptional mobilization.

Study summary

Investigating the acute effects of mobilization on these parameters offers innovative insights for the practitioner community and sheds light on the strategy's potential effectiveness in mitigating injury risk. Therefore, this study aims to assess the immediate effects of mobilization on static and dynamic balance in young male and female soccer players using a randomized, double-blinded study design.

Eligibility

Sex
ALL
Min age
14 Years
Max age
16 Years
Healthy volunteers
Accepted
Inclusion Criteria: * age between 14 to 16 years old, with regular soccer practice; * absence of lower limb and lumbar spine surgery or injuries within the last 6 months (hip, knee, ankle), no current pain in the hip, knee, or ankle joints, no hypermobility of the lower limb joints, and no history of neurological or connective tissue disorders; * availability for both assessment time points Exclusion Criteria: \-

Primary outcome measure(s)

  • Single leg standing — 2-3 seconds
    Participants will initiate the evaluation by standing on force plates (ForceDecks, VALD, Brisbane, Australia) in a standard standing posture.

Trial sites (1)

FacilityCityRegionStatus
AZS Central Academic Sports Center in Gdańsk Gdansk Poland

More Medical University of Gdansk trials in Poland

Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes Recruiting
Risk Factors and Exercise Effects on Abdominal Separation in Seniors Recruiting
The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners. Active, not recruiting
Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance Starting soon
GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery. Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06719752 on ClinicalTrials.gov ↗ ← All trials in Poland